Navigation Links
WuXi PharmaTech to Present at 27th Annual J.P. Morgan Healthcare Conference
Date:1/6/2009

SHANGHAI, China, Jan. 6 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Dr. Ge Li, the Company's Chairman and Chief Executive Officer, will present at the 27th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2009, at 4:30 pm Pacific Standard Time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The Company will broadcast its presentation. The public may access the broadcast through the Investor Relations section of the Company's web site: http://www.wuxiapptec.com .

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com .

    For more information, please contact:

     Ronald Aldridge
     Director of Investor Relations
     WuXi PharmaTech (Cayman) Inc.
     Tel:   +1-215-218-5515
     Email: Ron_Aldridge@wuxiapptec.com

     Juliane Snowden
     Vice President of Investor Relations
     Burns McClellan
     Tel:   +1-212-213-0006
     Email: Jsnowden@burnsmc.com

     Web:http://www.wuxiapptec.com

'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Pharmatech 2.0: Introducing Pharmatech Oncology
2. WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
3. WuXi PharmaTech Appoints Ying Han to Its Board of Directors
4. WuXi PharmaTech Announces Third Quarter 2008 Results
5. WuXi PharmaTech Signs New Collaboration Agreement With Pfizer
6. WuXi PharmaTech Schedules Third Quarter 2008 Earnings Release on Wednesday, November 12, 2008
7. WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
8. WuXi PharmaTech Appoints Jeff Leng to Its Board of Directors
9. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
10. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
11. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... ... 2017 , ... Tunnell Consulting has been solving the most complex ... challenges faced by life sciences, biotech and pharmaceuticals companies today is in interpreting the ... , who is well known in the industry and brings significant high-level expertise to ...
(Date:6/16/2017)... , ... June 16, 2017 , ... CTNext , ... Innovation Awards (EIA), held at The LOFT at Chelsea Piers in Stamford. , Nine ... to a panel of judges for an opportunity to secure $10,000 awards to help ...
(Date:6/15/2017)... ... 15, 2017 , ... angelMD announced the closure of a ... angelMD’s SVP of Corporate Development, served as the syndicate leader for this first ... Saranas’ recently announced $4 million Series B financing round. , Saranas is working ...
(Date:6/14/2017)... ... June 14, 2017 , ... The Thailand Board ... announces that they’re co-hosting a delegation from Thailand at BIO 2017 in San ... industry gathering in the world, regroups more than 1,100 biotech companies, academic institutions, ...
Breaking Biology Technology:
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
Breaking Biology News(10 mins):